Safety Policies & Visitor Guidelines |
Appointments & Scheduling |
Schedule a COVID vaccine appointment:
call us 8am to 5pm, Monday through Friday, at 267-758-4902.
English and French
English and French
Perelman Center for Advanced Medicine
Abramson Cancer Center, West Pavilion, 3rd Floor
3400 Civic Center Boulevard
Philadelphia, PA 19104
A facility of the Hospital of the University of Pennsylvania
The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
S. H. Small, J. Tang, Y. Ruzankina, D. W. Schoppy, M. R. Glineburg, D. J. Powel, F. Simpkins, F. B. Johnson, and E. J. Brown.: Induction of Interleukin-19 through JNK and cGAS-STING modulates DNA-damage-induced cytokine expression Science Signaling : 2021.
Zhang X, Devins K, Ko EK, Reyes MC, Simpkins F, Drapkin R, Schwartz L, Yoon JY: Mutational spectrum in clinically aggressive low-grade serous carcinoma/serous borderline tumors of the ovary—clinical significance of BRCA2 gene variants in genomically stable tumors. Gynecol Oncol 161(3):762-768 : 2021.
Wethington SL, Shah PD, Martin L, Tanyi JL, Latif N, Morgan M, Torigian D, Pagan C, Rodriguez D, Smith S, Dean E, Domchek S, Drapkin R, Shih, IM Armstrong DK, Gaillard S, Simpkins F: Combination of olaparib and ceralasertib shows clinical activity in acquired PARP inhibitor resistant recurrent ovarian cancer. Oral presentation, J Clinical Oncol (ASCO) : 2021.
Cadoo K, Simpkins F, Mathews C, Liu YL, Provencher D, McCormick C, ElNaggar AC, Altman AD, Gilbert L, Black D, Kabil N, Bennett J, Yu H, Munley J, Aghajanian C: Olaparib Treatment for Platinum-Sensitive Relapsed Ovarian Cancer by BRCA Mutation and Homologous Recombination Deficiency Status: Phase II LIGHT Study Primary Analysis. Oral presentation, J Clinical Oncol (ASCO) : 2021.
Cadoo K, Simpkins F, Mathews C, Altman A, Gilbert L, Liu Y, Black D, Munley J, Kabil N, Bennett J, Yu H, Aghajanian C: Olaparib treatment in patients with platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: secondary safety results from the Phase II LIGHT study. Oral presentation, Gynecol Oncol (SGO) : 2021.
Garcia-Soto A, Dauphin McKenzie N, Whicker M, Pearson JM, Jimenez EA, Portelance L, Hu JJ, Lucci JA, Qureshi, Kossenkov A, Mills G, Schwartz L, Maity A, Lin LL, Simpkins F: Phase I trial of nelfinavir added to cisplatin with concurrent pelvic radiation for locally advanced cervical cancer. Cancer 127(13):2279-2293 : 2021.
Pierini S, Tanyi JL, Simpkins F, George E, Uribe-Herranz M, Drapkin R, Burger R, Morgan MA, Facciabene A: Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic target. JCI Insight 5(16) : 2020.
Cadoo K, Simpkins F, Mathews C, Kabil N, Bennett J, Aghajanian C: Olaparib treatment in patients with platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: Phase II LIGHT study. Oral presentation, ASCO (Virtual) : 2020.
Kim H, Xu, H, George E, Hallberg D, Kumar s, Jagannathan V, Medvedev S, Kinose Y, Devins K, Verma P, Ly K, Wang Y, Greenbure RA, Schwartz L, Johnson N, Scharpf R, Mills G, Zhang R, Velculesco V, Brown E, Simpkins F: Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models. Nat Commun 11(1):3726 : 2020.
Lin LL, Lakomy DS, Ning MS, Simpkins F, Jhingran A: Combining novel agents with radiotherapy for gynecologic malignancies: beyond the era of cisplatin. Int J Gynecol Cancer 30(4):409-423 : 2020.
Jordan Center for Gynecologic Oncology at Penn Perelman Center for Advanced Medicine3400 Civic Center Blvd., 3rd Floor West
Patient appointments: 800-789-7366